Recent advances concerning the use of muramyl dipeptide derivatives as vaccine potentiators.
D000119:Acetylmuramyl-Alanyl-Isoglutamine / Q000276:immunology / Q000494:pharmacology*; D000276:Adjuvants, Immunologic / Q000494:pharmacology*; D000327:Adsorption; D000818:Animals; D000907:Antibodies, Bacterial / Q000096:biosynthesis; D001428:Bacterial Vaccines / Q000276:immunology*; D002352:Carrier Proteins / Q000276:immunology; D004168:Diphtheria Toxoid / Q000276:immunology; D006020:Glycopeptides / Q000494:pharmacology*; D006168:Guinea Pigs; D051379:Mice; D010963:Plasmodium falciparum / Q000276:immunology; D011749:Pyrogens / Q000494:pharmacology; D014349:Trypanosoma cruzi / Q000276:immunology
D000276:Adjuvants, Immunologic; D000907:Antibodies, Bacterial; D001428:Bacterial Vaccines; D002352:Carrier Proteins; D004168:Diphtheria Toxoid; D006020:Glycopeptides; D011749:Pyrogens; D000119:Acetylmuramyl-Alanyl-Isoglutamine